Takeda Settles "Pay-for-Delay" Consumer Claims for $1.85 Million

Takeda Settles "Pay-for-Delay" Consumer Claims for $1.85 Million

Source: 
BioSpace
snippet: 

Tokyo-based Takeda Pharmaceutical has agreed to pay $1.85 million as a settlement with consumers who filed a lawsuit against the company for allegedly delaying the commercial release of a generic, cheaper version of its ADHD drug.